Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Predicting early recurrence after microwave ablation in hepatocellular carcinoma: a clinicopathological-radiomics model based on ultrasound and identification of minimum ablation margin for high-risk tumors.

Created on 12 Aug 2026

Authors

Ting Liu, Chuang Wu, Tiantian Dong, Yingying Jia, Ying Duan, Yongxin Li, Fang Nie

Published in

Medical ultrasonography. Jul 17, 2026. Epub Jul 17, 2026.

Abstract

To develop a comprehensive clinicopathologic-radiomic model for predicting early recurrence (ER) after thermal ablation for hepatocellular carcinoma (HCC), and to explore optimal ablation strategies for high-risk tumors.
This multicenter retrospective study of 325 HCC patients undergoing microwave ablation divided them into training (n=182), internal (n=78), and external test sets (n=65). We extracted 3,499 radiomic features from pre-procedural ultrasound images and combined them with clinicopathological variables to train seven machine learning classifiers using 10-fold cross-validation. Model performance was assessed primarily by the area under the ROC curve, with decision curve and calibration analyses for clinical utility. The optimal minimal ablative margin (MAM) threshold for high-risk tumors was determined in the internal set using ROC analysis and validated externally.
The integrated clinicopathological-radiomics model demonstrated superior predictive performance, with an AUC of 0.870 (95% CI: 0.762-0.978) and showed good calibration and positive net benefit on decision curve analysis. SHapley Additive exPlanations analysis identified key predictive features, predominantly from arterial-phase CEUS images. In this cohort, a larger MAM (threshold 7.7 mm derived internally) was associated with lower ER in predicted high-risk tumors.
An integrated clinicopathological-radiomics model effectively predicts ER of HCC following microwave ablation and provides an effective strategy for high-risk tumors to reduce ER occurrence.

PMID:
42583722
Bibliographic data and abstract were imported from PubMed on 12 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement